KALA BIO, INC. Contractual Obligation, to be Paid, Year One
KALA BIO, INC. (KALA) had Contractual Obligation, to be Paid, Year One of $131.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueInNextTwelveMonths · last filed 2022-03-29
- 2021-12-31: Contractual Obligation, to be Paid, Year One $131.00K.
- 2021-09-30: Contractual Obligation, to be Paid, Year One $5.28M.
- 2021-06-30: Contractual Obligation, to be Paid, Year One $5.39M.
- 2021-03-31: Contractual Obligation, to be Paid, Year One $5.39M.
| Period end | Contractual Obligation, to be Paid, Year One |
|---|---|
| 2021-12-31 | $131.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $5.28M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.39M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.39M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $113.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $2.29M 10-Q · filed 2020-11-05 |
| 2019-12-31 | $113.00K 10-K · filed 2020-02-12 |
| 2018-12-31 | $413.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |